Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

929
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
929
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

33
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
33
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

512
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
512
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

32
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
32
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

42
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
42
Major Somatic Sensory Pathways01:28

Major Somatic Sensory Pathways

1.2K
Sensory impulses related to touch, pressure, vibration, and proprioception from various body parts, such as the limbs, trunk, neck, and posterior head, travel to the cerebral cortex through the posterior column-medial lemniscus pathway. The pathway’s name derives from the two white-matter tracts that convey the impulses: the spinal cord's posterior column and the brainstem's medial lemniscus. First-order sensory neurons extend their axons into the spinal cord, forming the...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Onset of Creutzfeldt-Jakob Disease After COVID-19: Navigating the Diagnostic Challenges and Clinical Evolution.

Case reports in neurological medicine·2025
Same author

Medically Refractory Neuroborreliosis Case Presented with Coexistance Involvements of Cranial 7 and 8 Nerves.

Neurology international·2021
Same author

Efficacy of Electrical Stimulation on Nerve Fiber Growth in Small Fiber Neuropathy.

Journal of clinical neuromuscular disease·2020
Same author

Electrodiagnostic findings in myotonic dystrophy: A study on 12 patients.

Neurology international·2019
Same author

Atypical presentation of Lyme neuroborreliosis related meningitis and radiculitis.

Neurology international·2019
Same author

The development of myasthenia gravis in a patient with facioscapulohumeral muscular dystrophy: case report and literature review.

Neurology international·2019

Related Experiment Video

Updated: Sep 8, 2025

Corneal Confocal Microscopy: A Novel Non-invasive Technique to Quantify Small Fibre Pathology in Peripheral Neuropathies
11:29

Corneal Confocal Microscopy: A Novel Non-invasive Technique to Quantify Small Fibre Pathology in Peripheral Neuropathies

Published on: January 3, 2011

26.7K

Small-Fiber Neuropathy Possibly Associated with COVID-19.

Ahmet Z Burakgazi1,2

  • 1Department of Neurology, Brown University, Providence, Rhode Island, USA.

Case Reports in Neurology
|June 15, 2022
PubMed
Summary

COVID-19 can affect the peripheral nervous system, potentially causing small-fiber neuropathy (SFN). This report highlights two cases, suggesting further investigation for neurological symptoms post-COVID-19 infection is warranted.

Keywords:
Case reportCoronavirus disease 2019PolyneuropathySkin biopsySmall-fiber neuropathy

More Related Videos

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.6K
Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
11:22

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies

Published on: April 29, 2013

13.3K

Related Experiment Videos

Last Updated: Sep 8, 2025

Corneal Confocal Microscopy: A Novel Non-invasive Technique to Quantify Small Fibre Pathology in Peripheral Neuropathies
11:29

Corneal Confocal Microscopy: A Novel Non-invasive Technique to Quantify Small Fibre Pathology in Peripheral Neuropathies

Published on: January 3, 2011

26.7K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.6K
Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
11:22

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies

Published on: April 29, 2013

13.3K

Area of Science:

  • Neurology
  • Infectious Diseases
  • Peripheral Nervous System Disorders

Background:

  • COVID-19 is known to cause neurological complications affecting both central and peripheral nervous systems.
  • Research on COVID-19's impact on the peripheral nervous system (PNS) remains limited.
  • Diagnosing PNS complications can be challenging due to limited access to specialized evaluations.

Observation:

  • This report details two cases presenting with symptoms suggestive of small-fiber neuropathy (SFN).
  • These cases occurred in the context of or following COVID-19 infection.
  • Paresthesia (tingling or numbness) was a key symptom observed in these patients.

Findings:

  • The presented cases suggest a potential association between COVID-19 infection and the development of small-fiber neuropathy (SFN).
  • The findings underscore the need for increased clinical awareness regarding this possible complication.
  • Diagnostic methods like nerve conduction studies and skin biopsies may be crucial for confirming SFN in post-COVID-19 patients.

Implications:

  • Increased consideration of SFN in patients experiencing paresthesia during or after COVID-19 infection is recommended.
  • Further research is warranted to elucidate the neuropathological mechanisms underlying COVID-19-related SFN.
  • Investigating the efficacy of immunomodulatory treatments, such as intravenous immunoglobulin, for COVID-19-associated SFN is crucial.